Beating cardiac arrhythmia
An arrhythmia refers to a condition when the heart beats too fast or too slow. Improving the clinical outcome for individuals with inherited arrhythmias – passed down from generation to generation – is the main objective of the EU-funded MOLEC ANTI-ARRHYT project. It will forge new paths for personalised risk stratification, drug design and clinical management. Characterised by diverse clinical manifestations, the project will investigate an important yet unexplored underlying cause – endogenous resilience and trigger factors that interact with mutated cardiac ion channels to alter arrhythmia severity. It will use front-line experimental and computational approaches, as well as cardiac potassium channels for this study.
Fields of science
Call for proposal
See other projects for this call